表紙
市場調查報告書

兒童疫苗的全球市場:成長,趨勢,預測(2019∼2024年)

Pediatric Vaccines Market - Growth, Trends, and Forecast (2019 - 2024)

出版商 Mordor Intelligence LLP 商品編碼 824070
出版日期 內容資訊 英文 113 Pages
商品交期: 2-3個工作天內
價格
Back to Top
兒童疫苗的全球市場:成長,趨勢,預測(2019∼2024年) Pediatric Vaccines Market - Growth, Trends, and Forecast (2019 - 2024)
出版日期: 2019年10月01日內容資訊: 英文 113 Pages
簡介

全球兒童疫苗市場2019∼2024年預計以11.7%的年複合成長率擴大。對疫苗接種的重要性和其認識,以及慢性病患的負擔增加,疫苗技術的進步,政府和非政府機關對研究開發的資金援助等推動市場成長。

本報告提供全球兒童疫苗市場相關調查,市場趨勢與各市場區隔趨勢,各地區預測,加入此市場的主要企業簡介等相關資訊彙整。

第1章 簡介

第2章 調查方法

第3章 摘要整理

第4章 市場趨勢

  • 市場概要
  • 推動市場的要素
    • 慢性病患的負擔增加和疫苗接種的重要性與認識
    • 疫苗的技術進步
    • 政府,非政府機關對研究開發的資金援助
  • 阻礙市場的要素
    • 疫苗接種成本
    • 低∼中所得國的醫療服務和醫療補償程度低
  • 波特五力分析

第5章 市場區隔

  • 各疫苗類型
    • 一價
    • 多效價
  • 各技術
    • 活病毒疫苗
    • 不活化疫苗
    • 類毒素疫苗
    • 共軛疫苗
    • 其他
  • 各用途
    • 感染疾病
    • 癌症
    • 過敏
    • 其他
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東、非洲
    • 南美

第6章 競爭趨勢

  • 企業簡介
    • GlaxoSmithKline PLC
    • Indian Immunologicals Limited
    • AstraZeneca
    • Merck & Co. Inc.
    • 田邊三菱製藥株式會社
    • Novartis AG
    • Pfizer Inc.
    • Sanofi SA
    • Seqirus (CSL Limited)

第7章 市場機會與未來趨勢

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 64990

Market Overview

The global pediatric vaccine market is expected to register 11.7% CAGR during the forecast period 2019-2024. The growth of the pediatric vaccines market is attributed due to the rising burden of chronic disease with the importance and awareness of immunization, technological advancements in vaccines, an increase in the government and non-government funding in R&D.

As immunization plays a significant role in modern medicine, there are several international programs for children, which may vary based on the disease. However, these programs are primarily driving the demand for the pediatric vaccines market.

There are several chronic diseases among children, which make them further susceptible to severe manifestations and complications with chronic diseases, For example, diseases, such as allergic, cardiorespiratory, hematologic, metabolic, and renal disorders, among others, lead to an increased risk of developing influenza, varicella, and pneumococcal infection. The parental understanding regarding these complications and immunization benefits is also required to raise awareness regarding pediatric vaccines. The television, by far, is the most common source of information, followed by health professionals, newspapers, and magazines. The uptake of pediatric vaccination has improved through community-based vaccination program, which communicates the benefits and effectiveness of vaccines, hence promoting the growth of the pediatric vaccines market.

Furthermore, government initiatives, like Vaccines for Children Program, provides vaccines to children who lack health insurance or cannot afford the cost of vaccination, which is funded by the Centers for Medicare and Medicaid Services (CMS) to the Centers for Disease Control (CDC), and approved by the Office of Management and Budget.

Scope of the Report

As per the scope of the report, pediatric vaccines are vaccines that stimulate the body's immune response, in order to prevent a specific disease in children.

Key Market Trends

The Conjugate Vaccine Segment, under Technology, is Expected to Grow at the Fastest Rate, during the Forecast Period

The conjugate vaccine segment held a maximum share in 2018, and is likely to witness a rapid growth during the forecast period, due to the increasing prevalence of pneumococcal and meningococcal infections, and rise in the awareness regarding the prevention of infection, by government initiatives.

The North American Region Holds the Largest Market Share of the Pediatric Vaccines Market and is Projected to Follow the Same Trend over the Forecast Period

North America is expected to be the primary region for the pediatric vaccines market, over the forecast period. The scheduled children immunization programs under the Centers for Disease Control and Prevention (CDC), high funding, wide commercial availability of vaccines, and the awareness in society regarding vaccines contribute to the sustained growth in the United States. In Canada, the vaccination schedule for infants and children are regularly updated by the Government of Canada, in collaboration with the Canadian Nursing Coalition for Immunization (CNCI) and the Canadian Immunization Committee (CIC). The well-structured healthcare services boost the growth of the pediatric vaccines market in North America.

Competitive Landscape

The pediatric vaccines market consists of several major players, including GlaxoSmithKline PLC, Merck & Co. Inc., Novartis AG, etc. The companies are implementing certain strategic initiatives, such as mergers, new product launches, acquisitions, and partnerships, which help them in strengthening their market position.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Burden of Chronic Diseases with the Importance and Awareness of Immunization
    • 4.2.2 Technological Advancements in Vaccines
    • 4.2.3 Increase in the Government and Non-government Funding in R&D
  • 4.3 Market Restraints
    • 4.3.1 Cost of Immunization
    • 4.3.2 Low Medical Coverage and Healthcare Services in Low- and Middle-income Countries
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Vaccine Type
    • 5.1.1 Monovalent
    • 5.1.2 Multivalent
  • 5.2 By Technology
    • 5.2.1 Live Attenuated
    • 5.2.2 Inactivated
    • 5.2.3 Toxoid
    • 5.2.4 Conjugate
    • 5.2.5 Other Technologies
  • 5.3 By Application
    • 5.3.1 Infectious Disease
    • 5.3.2 Cancer
    • 5.3.3 Allergy
    • 5.3.4 Other Applications
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 US
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 UK
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East & Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East & Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 GlaxoSmithKline PLC
    • 6.1.2 Indian Immunologicals Limited
    • 6.1.3 AstraZeneca
    • 6.1.4 Merck & Co. Inc.
    • 6.1.5 Mitsubishi Tanabe Pharma Corporation
    • 6.1.6 Novartis AG
    • 6.1.7 Pfizer Inc.
    • 6.1.8 Sanofi SA
    • 6.1.9 Seqirus (CSL Limited)

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top